![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DLD |
Gene summary for DLD |
![]() |
Gene information | Species | Human | Gene symbol | DLD | Gene ID | 1738 |
Gene name | dihydrolipoamide dehydrogenase | |
Gene Alias | DLDD | |
Cytomap | 7q31.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | A0A024R713 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1738 | DLD | HTA11_347_2000001011 | Human | Colorectum | AD | 1.03e-02 | 3.25e-01 | -0.1954 |
1738 | DLD | A015-C-203 | Human | Colorectum | FAP | 2.35e-09 | -2.03e-01 | -0.1294 |
1738 | DLD | A002-C-201 | Human | Colorectum | FAP | 3.38e-02 | -1.69e-01 | 0.0324 |
1738 | DLD | A001-C-108 | Human | Colorectum | FAP | 3.01e-06 | -2.07e-01 | -0.0272 |
1738 | DLD | A002-C-205 | Human | Colorectum | FAP | 1.38e-05 | -2.20e-01 | -0.1236 |
1738 | DLD | A001-C-104 | Human | Colorectum | FAP | 1.16e-03 | -1.55e-01 | 0.0184 |
1738 | DLD | A015-C-006 | Human | Colorectum | FAP | 8.38e-04 | -2.44e-01 | -0.0994 |
1738 | DLD | A015-C-106 | Human | Colorectum | FAP | 1.54e-05 | -1.69e-01 | -0.0511 |
1738 | DLD | A002-C-114 | Human | Colorectum | FAP | 1.78e-05 | -2.53e-01 | -0.1561 |
1738 | DLD | A015-C-104 | Human | Colorectum | FAP | 5.69e-09 | -2.02e-01 | -0.1899 |
1738 | DLD | A001-C-014 | Human | Colorectum | FAP | 3.64e-05 | -1.81e-01 | 0.0135 |
1738 | DLD | A002-C-016 | Human | Colorectum | FAP | 8.52e-10 | -1.99e-01 | 0.0521 |
1738 | DLD | A001-C-203 | Human | Colorectum | FAP | 3.93e-06 | -1.69e-01 | -0.0481 |
1738 | DLD | A002-C-116 | Human | Colorectum | FAP | 1.25e-08 | -1.62e-01 | -0.0452 |
1738 | DLD | A014-C-008 | Human | Colorectum | FAP | 3.16e-02 | -1.97e-01 | -0.191 |
1738 | DLD | A018-E-020 | Human | Colorectum | FAP | 7.38e-04 | -1.99e-01 | -0.2034 |
1738 | DLD | F034 | Human | Colorectum | FAP | 2.65e-06 | -2.06e-01 | -0.0665 |
1738 | DLD | CRC-3-11773 | Human | Colorectum | CRC | 2.90e-04 | -1.81e-01 | 0.2564 |
1738 | DLD | LZE2T | Human | Esophagus | ESCC | 4.29e-02 | 6.61e-01 | 0.082 |
1738 | DLD | LZE4T | Human | Esophagus | ESCC | 7.09e-14 | 4.13e-01 | 0.0811 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0046034 | Colorectum | AD | ATP metabolic process | 142/3918 | 277/18723 | 2.64e-29 | 8.26e-26 | 142 |
GO:0006091 | Colorectum | AD | generation of precursor metabolites and energy | 209/3918 | 490/18723 | 3.17e-28 | 6.61e-25 | 209 |
GO:0009060 | Colorectum | AD | aerobic respiration | 108/3918 | 189/18723 | 9.14e-28 | 1.43e-24 | 108 |
GO:0045333 | Colorectum | AD | cellular respiration | 119/3918 | 230/18723 | 3.21e-25 | 4.02e-22 | 119 |
GO:0006119 | Colorectum | AD | oxidative phosphorylation | 83/3918 | 141/18723 | 7.95e-23 | 8.30e-20 | 83 |
GO:0015980 | Colorectum | AD | energy derivation by oxidation of organic compounds | 143/3918 | 318/18723 | 2.78e-22 | 2.49e-19 | 143 |
GO:0022900 | Colorectum | AD | electron transport chain | 89/3918 | 175/18723 | 1.42e-18 | 8.91e-16 | 89 |
GO:0019646 | Colorectum | AD | aerobic electron transport chain | 53/3918 | 87/18723 | 5.58e-16 | 2.16e-13 | 53 |
GO:0042773 | Colorectum | AD | ATP synthesis coupled electron transport | 56/3918 | 95/18723 | 6.76e-16 | 2.22e-13 | 56 |
GO:0042775 | Colorectum | AD | mitochondrial ATP synthesis coupled electron transport | 56/3918 | 95/18723 | 6.76e-16 | 2.22e-13 | 56 |
GO:0022904 | Colorectum | AD | respiratory electron transport chain | 63/3918 | 114/18723 | 8.23e-16 | 2.45e-13 | 63 |
GO:0009150 | Colorectum | AD | purine ribonucleotide metabolic process | 142/3918 | 368/18723 | 4.29e-15 | 1.17e-12 | 142 |
GO:0006163 | Colorectum | AD | purine nucleotide metabolic process | 149/3918 | 396/18723 | 1.08e-14 | 2.80e-12 | 149 |
GO:0072521 | Colorectum | AD | purine-containing compound metabolic process | 153/3918 | 416/18723 | 4.34e-14 | 1.01e-11 | 153 |
GO:0009259 | Colorectum | AD | ribonucleotide metabolic process | 144/3918 | 385/18723 | 5.25e-14 | 1.13e-11 | 144 |
GO:0019693 | Colorectum | AD | ribose phosphate metabolic process | 145/3918 | 396/18723 | 3.01e-13 | 5.71e-11 | 145 |
GO:0009117 | Colorectum | AD | nucleotide metabolic process | 168/3918 | 489/18723 | 2.20e-12 | 3.36e-10 | 168 |
GO:0006753 | Colorectum | AD | nucleoside phosphate metabolic process | 169/3918 | 497/18723 | 4.99e-12 | 6.98e-10 | 169 |
GO:0006120 | Colorectum | AD | mitochondrial electron transport, NADH to ubiquinone | 32/3918 | 51/18723 | 1.12e-10 | 1.11e-08 | 32 |
GO:0006090 | Colorectum | AD | pyruvate metabolic process | 47/3918 | 106/18723 | 4.85e-08 | 2.55e-06 | 47 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa000109 | Liver | Cirrhotic | Glycolysis / Gluconeogenesis | 32/2530 | 67/8465 | 1.50e-03 | 7.80e-03 | 4.81e-03 | 32 |
hsa0064021 | Liver | Cirrhotic | Propanoate metabolism | 18/2530 | 32/8465 | 1.66e-03 | 8.01e-03 | 4.94e-03 | 18 |
hsa003802 | Liver | Cirrhotic | Tryptophan metabolism | 22/2530 | 42/8465 | 1.85e-03 | 8.37e-03 | 5.16e-03 | 22 |
hsa0031021 | Liver | Cirrhotic | Lysine degradation | 29/2530 | 63/8465 | 4.81e-03 | 1.74e-02 | 1.07e-02 | 29 |
hsa0120031 | Liver | Cirrhotic | Carbon metabolism | 64/2530 | 115/8465 | 6.37e-09 | 1.18e-07 | 7.26e-08 | 64 |
hsa0028031 | Liver | Cirrhotic | Valine, leucine and isoleucine degradation | 32/2530 | 48/8465 | 1.45e-07 | 2.02e-06 | 1.24e-06 | 32 |
hsa0062011 | Liver | Cirrhotic | Pyruvate metabolism | 29/2530 | 47/8465 | 5.90e-06 | 5.95e-05 | 3.67e-05 | 29 |
hsa0063011 | Liver | Cirrhotic | Glyoxylate and dicarboxylate metabolism | 20/2530 | 30/8465 | 3.36e-05 | 2.54e-04 | 1.57e-04 | 20 |
hsa012401 | Liver | Cirrhotic | Biosynthesis of cofactors | 66/2530 | 153/8465 | 3.11e-04 | 1.99e-03 | 1.23e-03 | 66 |
hsa002601 | Liver | Cirrhotic | Glycine, serine and threonine metabolism | 22/2530 | 40/8465 | 7.85e-04 | 4.51e-03 | 2.78e-03 | 22 |
hsa0001012 | Liver | Cirrhotic | Glycolysis / Gluconeogenesis | 32/2530 | 67/8465 | 1.50e-03 | 7.80e-03 | 4.81e-03 | 32 |
hsa0064031 | Liver | Cirrhotic | Propanoate metabolism | 18/2530 | 32/8465 | 1.66e-03 | 8.01e-03 | 4.94e-03 | 18 |
hsa0038011 | Liver | Cirrhotic | Tryptophan metabolism | 22/2530 | 42/8465 | 1.85e-03 | 8.37e-03 | 5.16e-03 | 22 |
hsa0031031 | Liver | Cirrhotic | Lysine degradation | 29/2530 | 63/8465 | 4.81e-03 | 1.74e-02 | 1.07e-02 | 29 |
hsa0120041 | Liver | HCC | Carbon metabolism | 89/4020 | 115/8465 | 3.92e-11 | 6.56e-10 | 3.65e-10 | 89 |
hsa0028041 | Liver | HCC | Valine, leucine and isoleucine degradation | 41/4020 | 48/8465 | 4.84e-08 | 7.05e-07 | 3.92e-07 | 41 |
hsa0002021 | Liver | HCC | Citrate cycle (TCA cycle) | 28/4020 | 30/8465 | 1.08e-07 | 1.44e-06 | 8.02e-07 | 28 |
hsa012402 | Liver | HCC | Biosynthesis of cofactors | 103/4020 | 153/8465 | 4.67e-07 | 5.05e-06 | 2.81e-06 | 103 |
hsa0031041 | Liver | HCC | Lysine degradation | 47/4020 | 63/8465 | 1.02e-05 | 7.58e-05 | 4.22e-05 | 47 |
hsa0062021 | Liver | HCC | Pyruvate metabolism | 37/4020 | 47/8465 | 1.10e-05 | 8.03e-05 | 4.46e-05 | 37 |
Page: 1 2 3 4 5 6 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DLD | SNV | Missense_Mutation | c.797N>C | p.Gln266Pro | p.Q266P | P09622 | protein_coding | tolerated(0.09) | possibly_damaging(0.503) | TCGA-A8-A08J-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |
DLD | SNV | Missense_Mutation | c.83N>T | p.Ser28Phe | p.S28F | P09622 | protein_coding | tolerated(0.66) | benign(0) | TCGA-AO-A03T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | |
DLD | SNV | Missense_Mutation | novel | c.729A>C | p.Glu243Asp | p.E243D | P09622 | protein_coding | deleterious(0.02) | probably_damaging(0.998) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
DLD | SNV | Missense_Mutation | c.219N>G | p.Asn73Lys | p.N73K | P09622 | protein_coding | deleterious(0) | possibly_damaging(0.511) | TCGA-CA-6719-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
DLD | SNV | Missense_Mutation | c.339N>A | p.Met113Ile | p.M113I | P09622 | protein_coding | tolerated(0.31) | benign(0) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
DLD | SNV | Missense_Mutation | c.1168C>T | p.Pro390Ser | p.P390S | P09622 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-G4-6302-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
DLD | SNV | Missense_Mutation | rs371807385 | c.944G>A | p.Arg315Gln | p.R315Q | P09622 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
DLD | SNV | Missense_Mutation | rs201652869 | c.875C>T | p.Ser292Phe | p.S292F | P09622 | protein_coding | deleterious(0.02) | possibly_damaging(0.727) | TCGA-AG-A02N-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Chemotherapy | folinic | CR |
DLD | insertion | Frame_Shift_Ins | novel | c.626_627insA | p.Val212SerfsTer32 | p.V212Sfs*32 | P09622 | protein_coding | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
DLD | deletion | Frame_Shift_Del | c.627delN | p.Val212PhefsTer12 | p.V212Ffs*12 | P09622 | protein_coding | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |